About Bolder Science

Our mission is to provide healthcare professionals with unbiased clinical research information, easily.

Currently, you can access the following clinical trials being conducted worldwide:

342,868 studies
in
216 countries
Clinical trial information and results are updated daily from ClinicalTrials.gov. The latest data update was conducted on 08/05/2020.
This website is for US healthcare professionals

Log In to Bolder Science

or

Don't have an account? Sign Up

Please enter your email address.

You will receive a link to create a new password via email.

Log In

Create an Account

or
(optional) ?

Welcome, !

Please complete the following 4 questions to ensure you receive the information that best suits your needs.

Clinical Trials of Interest

When I’m looking for information on clinical trials, I usually am interested in...

finding clinical trials in which to enroll my patients

Rarely Often

finding newly launched clinical trials (for all phases)

Rarely Often

updates on status changes for clinical trials

Rarely Often

pipeline molecules

Rarely Often

Drug Interventions

Enter up to 3 drug interventions you are currently interested in:

Clinical trial information and results are updated daily from ClinicalTrials.gov. The latest data update was conducted on 08/05/2020.

Effects of Early Oral Feeding After Resection of Gastric Cancer

Clinicaltrials.gov identifier NCT00606619

Recruitment Status Completed

First Posted February 4, 2008

Last update posted May 28, 2010

Study Description

Brief summary:

The aim of this study is to determine whether early oral feeding after curative resection for gastric cancer would be tolerable and give an effect on the recovery.

  • Condition or Disease:Gastric Cancer
  • Intervention/Treatment: Other: Conventional feeding
    Other: Early oral feeding
  • Phase: Phase 3
Detailed Description

Most patients who undergo gastric resection for gastric cancer have maintained going on a fast of over three days after operation. Surgeons have believed that early oral feeding might worsen patients' condition by prolonged postoperative ileus. Therefore, patients received nothing by oral route until resolution of the ileus. However, the current trend toward minimal operative injury and early discharge from hospital. In addition, development of operative technique and instrument make the operation time to be short and the patients to be fast recovery, and thus it is possible to feed early in less than two days after operation. The aim of this study is to determine whether early oral feeding after curative resection for gastric cancer would be tolerable and give an effect on the recovery. We collect fifty-eight patients for this study and divide into two groups using randomization method. In the early feeding group, patients will receive the liquid diet two day after operation followed by soft diet postoperative three day. Meanwhile, the patients who categorized into control group will start the liquid diet postoperative four day followed by soft diet postoperative six day. We evaluate the morbidity or mortality rate and laboratory findings. Of course, it is supposed to be same in amount of fluid and calories between two groups.

Study Design
  • Study Type: Interventional
  • Actual Enrollment: 58 participants
  • Allocation: Randomized
  • Intervention Model: Parallel Assignment
  • Masking: None (Open Label) ()
  • Primary Purpose: Treatment
  • Official Title: Phase III Clinical Trial for Effect Early Oral Feeding on Recovery After Resection of Gastric Cancer
  • Study Start Date: July 2008
  • Actual Primary Completion Date: February 2009
  • Actual Study Completion Date: February 2009
Arms and interventions
Arm Intervention/treatment
No Intervention: 1
Conventional feeding : They begin ingesting sips of water on third postoperative day and continued with a liquid diet for the next two days. Patients were given a soft diet on sixth postoperative day.
Other: Conventional feeding
Procedure of Conventional feeding group: Patients are supplied water on day 3 after operation, liquid diet on day 4 and 5 and soft diet on 6 day.
Experimental: 2
Early oral feeding : The patients begin ingesting sips of water on the first postoperative day. If they are tolerable, they continued with a clear liquid diet the next day and a soft diet on the third post operative day.
Other: Early oral feeding
Procedure of Early oral feeding group: Patients are supplied water on day 1 after operation, liquid diet on day 2 and soft diet on day 3 day.
Outcome Measures
  • Primary Outcome Measures: 1. Days of hospital stay after operation [ Time Frame: within 30 days after operation ]
    We measure the length of hospital stay after operation
  • Secondary Outcome Measures: 1. Laboratory findings after operation: Albumin, complete blood count, total cholesterol, cholinesterase and C-reactive protein are measured [ Time Frame: 1,3,5 and 7 day after operation ]
  • 2. Symptom of Patients: Question to patients about symptoms [ Time Frame: before operation and 1,3,5,7 day after operation ]
  • 3. Cost effectiveness: Total cost duration of hospitalization [ Time Frame: within 30 days after admission ]
    We measure total cost from admission to discharge after operation
  • 4. Quality of life: EORTC QLQ30, STO22 [ Time Frame: 1,2 and 3 month after operation ]
  • 5. Immunologic Outcomes : IL-1, IL-2, IL-6, IL-8, TNF-a will by measured by ELISA [ Time Frame: before operation and 1,3,5,7 day after operation ]
  • 6. Postoperative morbidity rate in hospital days: Clinically definite morbidity confirmed by physicians according to offered protocol [ Time Frame: within 30 days after operation ]
    We observe the occurrence of morbidity after operation
  • 7. Day of recovery of bowel sound and flatus: Evidence of recovery of bowel sound by physician's examination and Evidence of first flatus by question to patient [ Time Frame: within 30 days after operation ]
    We measure the days of flatus within 30 days after operation
Eligibility Criteria
  • Ages Eligible for Study: 20 to 75 Years (Adult, Older Adult)
  • Sexes Eligible for Study: All
  • Accepts Healthy Volunteers: No
Criteria

Inclusion Criteria:

Patients who underwent gastrectomy for adenocarcinoma of stomach with following criteria:

1. Performed curative resection

2. Have The American Society of Anaesthesiologists (ASA) score of less than 3

Exclusion Criteria:

1. Patients who have simultaneously other cancer.

2. Patients who underwent gastric resection at past time.

3. Patients who have cancer with bleeding or perforation or obstruction.

4. Patients who have any injury to the pancreas capsule on operation.

5. Patients who get pregnancy.

6. Patients who are treating diabetics with Insulin.

Contacts and Locations
Contacts
Locations

Korea, Republic of
St Mary's Hospital, The Catholic University of Korea
Seoul

Sponsors and Collaborators

The Catholic University of Korea

Investigators

Principal Investigator: Hae Myung Jeon, MD Department of Surgery, St Mary's Hospital, The Catholic University of Korea

Study Director: Hoon Hur, MD Department of Surgery, St Mary's Hospital, The Catholic University of Korea